PGI5 THE COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2B (I2KD) PLUS RIBAVIRIN VS. INTERFERON ALFA-2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C (CHC) IN A DEVELOPING COUNTRY—BRAZIL
| Autor: | Fonseca, MC, Araujo, GTB |
|---|---|
| Zdroj: | In Value in Health 2005 8(6):A119-A120 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect